297 related articles for article (PubMed ID: 32800939)
1. Development of a quantitative method to evaluate the printability of filaments for fused deposition modeling 3D printing.
Xu P; Li J; Meda A; Osei-Yeboah F; Peterson ML; Repka M; Zhan X
Int J Pharm; 2020 Oct; 588():119760. PubMed ID: 32800939
[TBL] [Abstract][Full Text] [Related]
2. Strategies and mechanisms to improve the printability of pharmaceutical polymers Eudragit® EPO and Soluplus®.
Yang Y; Wang H; Xu X; Yang G
Int J Pharm; 2021 Apr; 599():120410. PubMed ID: 33639229
[TBL] [Abstract][Full Text] [Related]
3. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
4. Development of a Simple Mechanical Screening Method for Predicting the Feedability of a Pharmaceutical FDM 3D Printing Filament.
Nasereddin JM; Wellner N; Alhijjaj M; Belton P; Qi S
Pharm Res; 2018 May; 35(8):151. PubMed ID: 29855818
[TBL] [Abstract][Full Text] [Related]
5. Roadmap to 3D-Printed Oral Pharmaceutical Dosage Forms: Feedstock Filament Properties and Characterization for Fused Deposition Modeling.
Aho J; Bøtker JP; Genina N; Edinger M; Arnfast L; Rantanen J
J Pharm Sci; 2019 Jan; 108(1):26-35. PubMed ID: 30445005
[TBL] [Abstract][Full Text] [Related]
6. Investigation on hot melt extrusion and prediction on 3D printability of pharmaceutical grade polymers.
Tabriz AG; Scoutaris N; Gong Y; Hui HW; Kumar S; Douroumis D
Int J Pharm; 2021 Jul; 604():120755. PubMed ID: 34052338
[TBL] [Abstract][Full Text] [Related]
7. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
8. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.
Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK
Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
Chung S; Zhang P; Repka MA
Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
[TBL] [Abstract][Full Text] [Related]
10. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling.
Melocchi A; Parietti F; Maroni A; Foppoli A; Gazzaniga A; Zema L
Int J Pharm; 2016 Jul; 509(1-2):255-263. PubMed ID: 27215535
[TBL] [Abstract][Full Text] [Related]
11. Formulation development and process analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of medicines.
Korte C; Quodbach J
Pharm Dev Technol; 2018 Dec; 23(10):1117-1127. PubMed ID: 29368974
[TBL] [Abstract][Full Text] [Related]
12. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
13. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
14. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
15. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
16. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance.
Bandari S; Nyavanandi D; Dumpa N; Repka MA
Adv Drug Deliv Rev; 2021 May; 172():52-63. PubMed ID: 33571550
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
[TBL] [Abstract][Full Text] [Related]
18. Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery.
Tan DK; Maniruzzaman M; Nokhodchi A
Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30356002
[TBL] [Abstract][Full Text] [Related]
19. M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines.
Elbadawi M; Muñiz Castro B; Gavins FKH; Ong JJ; Gaisford S; Pérez G; Basit AW; Cabalar P; Goyanes A
Int J Pharm; 2020 Nov; 590():119837. PubMed ID: 32961295
[TBL] [Abstract][Full Text] [Related]
20. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.
Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA
Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
